Trump Backtracks on Plan for New Controls on N.I.H. Grants
Democrats and Republicans in Congress opposed the creation of a commission with the power to veto federal research awards.
The Trump administration's decision to backtrack on a plan to impose new controls on National Institutes of Health (N.I.H.) grants is a notable development in the ongoing debate over research funding and oversight in the United States. The proposed commission would have had the power to veto federal research awards, sparking concerns among both Democrats and Republicans in Congress.
The opposition to the plan highlights the delicate balance between ensuring accountability in research funding and avoiding undue interference in the scientific process. The N.I.H. is a major source of funding for biomedical research, and any changes to its grant-making process could have significant implications for the scientific community. The fact that lawmakers from both parties opposed the plan suggests that there is broad support for maintaining the current peer-review process, which is widely regarded as a cornerstone of scientific integrity.
As the research community continues to navigate the complexities of funding and oversight, it's worth watching how this development affects the broader conversation around science policy in the United States. The N.I.H. is a key player in the global scientific landscape, and any changes to its operations could have far-reaching implications for research collaboration and innovation. What's next to watch is how the administration will engage with lawmakers and the scientific community to address concerns around research funding and oversight.
Originally reported by nytimes.com. EuroNewsletter adds analysis for general news readers.